Cargando…
The role of botulinum toxin A in treating neurogenic bladder
Neurogenic detrusor overactivity (NDO) can result in lower and upper urinary tract complications and eventually even in end-stage kidney failure. Since the driving force of this clinical cascade is high bladder pressure, controlling intravesical pressure in NDO patients improves both quality of life...
Autores principales: | Weckx, Filip, Tutolo, Manuela, De Ridder, Dirk, Van der Aa, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739988/ https://www.ncbi.nlm.nih.gov/pubmed/26904413 http://dx.doi.org/10.3978/j.issn.2223-4683.2016.01.10 |
Ejemplares similares
-
Botulinum Toxin-A Therapy in Pediatric Urology: Indications for the Neurogenic and Non-Neurogenic Neurogenic Bladder
por: Dyer, Lori, et al.
Publicado: (2009) -
Pharmacotherapy in Pediatric Neurogenic Bladder Intravesical Botulinum Toxin Type A
por: Sager, Cristian, et al.
Publicado: (2012) -
Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
por: Wu, Shu-Yu, et al.
Publicado: (2021) -
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A
por: Paradella, Ana Claudia, et al.
Publicado: (2016) -
Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)